Jump to content
IndiaDivine.org

Buffing the Halo

Rate this topic


Guest guest

Recommended Posts

" HSI - Jenny Thompson " <hsiresearch

HSI e-Alert - Buffing the Halo

Tue, 24 Jan 2006 06:50:00 -0500

 

 

 

 

HSI e-Alert - Buffing the Halo

 

Health Sciences Institute e-Alert

 

 

****************************************************

January 24, 2006

 

 

****************************************************

 

Dear Reader,

 

I would be lying if I said I didn't enjoy highly questionable

statements made by " experts. "

 

For instance, a recent American Heart Association (AHA) press release

carried a quote from a researcher who's also a doctor. In commenting

on a study that found non-steroidal anti-inflammatory drugs (NSAIDs)

to raise the risk of premature death, he stated: " There is no doubt

about the beneficial effects of aspirin among patients after heart

attack...and the scientific evidence is undeniable. "

 

No doubt? Maybe he meant to say " plenty of doubt. " But I doubt it.

 

-----------

Half in the bag

-----------

 

I'll back up a little bit.

 

The study mentioned above comes from a university hospital in

Copenhagen, Denmark. Researchers evaluated medical records of more

than 58,000 heart attack patients. The records were matched against

prescriptions for COX-2 inhibitors and NSAIDs that were filled by the

patients after their heart attacks. (The seven-year study period ended

in 2002, so Vioxx was among the COX-2 inhibitors used; long before it

was taken off the market in 2004.)

 

After assessing the risk of a second heart attack or death by any

cause, researchers found that patients taking these medications had a

" strikingly higher risk of death " within the study period compared to

heart attack patients who didn't use the drugs. Furthermore, higher

doses of the drugs were associated with an even higher risk of death.

 

But there was a curveball in the results: Use of COX-2 inhibitors or

NSAIDs didn't increase the risk of a second heart attack. According to

the AHA press release (the study hasn't been published yet),

researchers are now examining death certificates to assess the

different causes of death.

 

Hmm...wouldn't that have been the obvious thing to do BEFORE they

started reporting on the results?

 

-----------

Evidence denied

-----------

 

Besides the fact that other studies have shown that Vioxx and (to a

lesser extent) other COX-2 inhibitors increase heart attack risk,

there was yet another curveball in the study: Aspirin intake wasn't

assessed.

 

Aspirin is probably the most widely used NSAID. But according to

Gunnar H Gislason, M.D., the lead author of the study, the absence of

aspirin data is not a factor. Why? Because according to Dr. Gislason

(let's look at his quote again): " There is no doubt about the

beneficial effects of aspirin among patients after heart attack...and

the scientific evidence is undeniable. "

 

Not so fast, Doc.

 

In the e-Alert " Double-Edged Wonder " (7/14/04), I looked at a UK study

that examined the use of aspirin and prescription blood thinner

(warfarin) in about 280 patients who had suffered either heart attack

or stroke.

 

After an average follow up period of more than two years, neither the

aspirin nor the warfarin provided any greater protection against

death, nonfatal stroke, or nonfatal heart attacks than a placebo.

Subjects who received aspirin therapy, however, were nearly TWICE AS

LIKELY to suffer a heart attack or stroke as were those who took

warfarin or placebo. Gastrointestinal problems were also elevated in

the aspirin group.

In an interview with Reuters Health, the lead researcher of the study,

Dr. John G. F. Cleland, stated that any theoretical benefit of using

aspirin after a heart attack " is outweighed by real evidence of harm. "

 

-----------

Freshly buffed halo

----------

 

Last week a new aspirin study was published in the Journal of the

American Medical Association. The study found that women apparently

receive modest stroke protection from aspirin therapy, but little

cardiovascular protection. The opposite is true for men.

 

Of course, the media reports about this research treated aspirin's

saintly status as a given, furthering the 20th Century myth that this

drug somehow works miracles with no side effects.

 

Tell your family and friends: Aspirin is a drug. And while it may have

its place, it should be used just as you would use any drug: with caution.

 

 

 

 

****************************************************

 

....and another thing

 

It's Déjà vu (with a capital " D " ) all over again.

 

In a recent e-Alert I noted that we've been hearing a lot about

vitamin D lately. And as it happens I've also recently sent you two

e-Alerts about the prevention of periodontitis (gum disease). Now

these two topics have come together in a new study from the Goldman

School of Dental Medicine at Boston University (BU).

 

Gingivitis is an inflammation of the gums and the precursor of

periodontitis. The BU researchers conducted a trial to find what

association vitamin D might have with gingival inflammation.

 

Using information from the third National Health and Nutrition

Examination Survey (NHANES III), researchers assessed dental records

along with blood sample data that revealed vitamin D levels in 6,700

subjects. Those with the highest D levels were 20 percent less likely

to have gingival inflammation compared to subjects with the lowest D

levels.

 

The combined results of these three periodontitis studies show that

high levels of vitamins C and D help prevent gum disease, especially

in non-smokers who also exercise.

 

To Your Good Health,

 

Jenny Thompson

 

 

 

 

 

****************************************************

 

 

 

Sources:

 

" Most NSAIDs Raise Risk Of Death After Heart Attack " American Heart

Association, 11/14/05, sciencedaily.com

" The Warfarin/Aspirin Study in Heart Failure (WASH): a Randomized

Trial Comparing Antithrombotic Strategies for Patients with Heart

Failure " American Heart Journal, Vol. 148, No. 1, July 2004,

ncbi.nlm.nih.gov

" Association Between Serum Concentrations of 25-Hydroxyvitamin D and

Gingival Inflammation " American Journal of Clinical Nutrition, Vol.

82, No. 3, September 2005, ajcn.org

 

**********************

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...